Citrullinated proteins in rheumatoid arthritis

Frontiers in Bioscience

Volumn 10, Issue 1, 2005, Pages 54-64

  Yamada, Ryo ^a,c   Suzuki, Akari ^a   Chang, Xiaotian ^a   Yamamoto, Kazuhiko ^a,b  

^a RIKEN   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NONE   (Japan)

Author keywords

Anti Citrullinated Peptide Antibody; Citrulline; PADI4; Review; Rheumatoid Arthritis

Indexed keywords

ARGININE; AUTOANTIBODY; CITRULLINE; PEPTIDE ANTIBODY; PROTEIN ARGININE DEIMINASE;

ANTIGENICITY; ARTICLE; AUTOIMMUNITY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 17444431949     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1506     Document Type: Article

References (47)

1. Athanasou, N. A. and J. Quinn: Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow derived cells. Ann Rheum Dis 50, 311-315 (1991)
2. Denning, S. M., P. T. Le, K. H. Singer and B. F. Haynes: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144, 7-15 (1990)
3. Veale, D. J. and C. Maple: Cell adhesion molecules in rheumatoid arthritis. Drugs Aging 9, 87-92 (1996)
4. Nepom, G. T: Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv Immunol 68, 315-332 (1998)
5. Tagaya, Y., R. N. Bamford, A. P. DeFilippis and T. A. Waldmann: IL-15, a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329-336 (1996)
6. McGee, B, R. E. Small and R. Singh: B lymphocytic clonal expansion in rheumatoid arthritis. J Rheumatol 23, 36-43 (1996)
7. van Boekel, M. A., E. R. Vossenaar, F. H. van den Hoogen, W. J. van Venrooij: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4, 87-93 (2002)
8. Suzuki, A., R. Yamada and X. Chang: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet (2003)
9. Vossenaar, E. R., A. J. Zendman, W. J. van Venrooij and G. J. Pruijn: PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118 (2003)
10. Senshu, T., K. Akiyama, A. Ishigami, K. Nomura: Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. J Dermatol Sci 21, 113-126 (1999)
11. Zhou, S. R., J. N. Whitaker, D. D. Wood, M. A. Moscarello: Immunological analysis of the amino terminal and the C8 isomer of human myelin basic protein. J Neuroimmunol 46, 91-96 (1993)
12. Simon, M., E. Girbal, M. Sebbag: The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest 92, 1387-1393 (1993)
13. Girbal-Neuhauser, E, J. J. Durieux and M. Arnaud: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162, 585-594 (1999)
14. Schellekens, G. A., B. A. de Jong, F. H. van den Hoogen, L. B. van de Putte and W. J. van Venrooij: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101, 273-281 (1998)
15. Senshu, T., S. Kan, H. Ogawa, M. Manabe, H. Asaga: Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 225, 712-719 (1996)
16. Hagiwara, T., K. Nakashima, H. Hirano, T. Senshu, M. Yamada: Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophvs Res Commun 290, 979-983 (2002)
17. Asaga, H., M. Yamada, T. Senshu: Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 243, 641-646 (1998)
18. Masson-Bessiere, C., M. Sebbag, E. Girbal-Neuhauser: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166, 4177-4184 (2001)
19. van Stipdonk, M. J., A. A. Willems, S. Amor: T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int Immunol 10, 943-950 (1998)
20. Rathmell, J. C. and C. B. Thompson: The central effectors of cell death in the immune system. Annu Rev Immunol 17, 781-828 (1999)
21. Piacentini, M. and V. Colizzi: Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today 20, 130-134 (1999)
22. Hershko, A. and A. Ciechanover: The ubiquitin system. Annu Rev Biochem 67, 425-479 (1998)
23. Tarcsa, E., L. N. Marekov, G. Mei: Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271, 30709-30716 (1996)
24. Hill, J. A., S. Southwood, A. Sette: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171, 538-541 (2003)
25. Arnett, F. C., S. M. Edworthy, D. A. Bloch: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-324 (1988)
26. Wolfe, F., M. A. Cathey, F. K. Roberts: The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum 34, 951-960 (1991)
27. Shmerling, R. H., T. L. Delbanco: The rheumatoid factor: an analysis of clinical utility. Am J Med 91, 528-534 (1991)
28. Sondag-Tschroots, I. R., C. Aaij, J. W. Smit, T. E. Feltkamp: The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis 38, 248-251 (1979)
29. Young, B. J., R. K. Mallya, R. D. Leslie, C. J. Clark, T. J. Hamblin: Anti-keratin antibodies in rheumatoid arthritis. Br Med J 2, 97-99 (1979)
30. Vincent, C., F. de Keyser, C. Masson-Bessiere: Antiperinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 58, 42-48 (1999)
31. Vincent, C., G. Serre and F. Lapeyre: High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis 48, 712-722 (1989)
32. Despres, N., G. Boire, F. J. Lopez-Longo and H. A. Menard: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 21, 1027-1033 (1994)
33. Senshu, T., K. Akiyama, S. Kan: Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol 105, 163-169 (1995)
34. Schellekens, G. A., H. Visser, B. A. de Jong: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43, 155-163 (2000)
35. Goldbach-Mansky, R, J. Lee and A. McCoy: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2, 236-243 (2000)
36. Bizzaro, N., G. Mazzanti, E. Tonutti, D. Villalta, R. Tozzoli: Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47, 1089-1093 (2001)
37. Bas, S., T. V. Perneger and M. Seitz: Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 41, 809-814 (2002)
38. Suzuki, K., T. Sawada, A. Murakami: High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32, 197-204 (2003)
39. Nogueira, L., M. Sebbag, C. Vincent: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 60, 882-887 (2001)
40. Vincent, C., L. Nogueira, M. Sebbag: Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 46, 2051-2058 (2002)
41. Rantapaa-Dahlqvist, S., B. A. de Jong, E. Berglin: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48, 2741-2749 (2003)
42. Raats, J. M., E. M. Wijnen, G. J. Pruijn, F. H. van den Hoogen, W. J. van Venrooij: Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J Rheumatol 30, 1696-1711 (2003)
43. Masson-Bessiere, C., M. Sebbag, J. J. Durieux: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 119, 544-552 (2000)
44. Reparon-Schuijt, C. C., W. J. van Esch, C. van Kooten: Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 44, 41-47 (2001)
45. Vossenaar, E. R., S. Nijenhuis, M. M. Helsen: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48, 2489-2500 (2003)
46. Wood, D. D., J. M. Bilbao, P. O'Connors, M. A. Moscarello: Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40, 18-24 (1996)
47. Ishida-Yamamoto, A., T. Senshu, H. Takahashi: Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol 114, 701-705 (2000)